Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and Outcome.
Moser E, Ura A, Vogel L, Steiger K, Mogler C, Evert M, Märkl B, Scheidhauer K, Martignoni M, Friess H, von Werder A, Marinoni I, Perren A, Klöppel G, Kasajima A. Moser E, et al. Among authors: perren a. Mod Pathol. 2024 Aug 13;37(11):100595. doi: 10.1016/j.modpat.2024.100595. Online ahead of print. Mod Pathol. 2024. PMID: 39147030 Free article.
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer.
Künzli BM, Bernlochner MI, Rath S, Käser S, Csizmadia E, Enjyoji K, Cowan P, d'Apice A, Dwyer K, Rosenberg R, Perren A, Friess H, Maurer CA, Robson SC. Künzli BM, et al. Among authors: perren a. Purinergic Signal. 2011 Jun;7(2):231-41. doi: 10.1007/s11302-011-9228-9. Epub 2011 Apr 2. Purinergic Signal. 2011. PMID: 21484085 Free PMC article.
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms.
Elvebakken H, Venizelos A, Perren A, Couvelard A, Lothe IMB, Hjortland GO, Myklebust TÅ, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Vestermark LW, Knappskog S, Sorbye H. Elvebakken H, et al. Among authors: perren a. Br J Cancer. 2024 Sep;131(4):676-684. doi: 10.1038/s41416-024-02773-w. Epub 2024 Jun 22. Br J Cancer. 2024. PMID: 38909137 Free PMC article.
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies.
April-Monn SL, Kirchner P, Detjen K, Bräutigam K, Trippel MA, Grob T, Statzer C, Maire RS, Kollàr A, Chouchane A, Kunze CA, Horst D, Sadowski MC, Schrader J, Marinoni I, Wiedenmann B, Perren A. April-Monn SL, et al. Among authors: perren a. NPJ Precis Oncol. 2024 Mar 1;8(1):59. doi: 10.1038/s41698-024-00549-2. NPJ Precis Oncol. 2024. PMID: 38429350 Free PMC article.
381 results